KXIP vs KKR Live Score

The U.S. Food and Drug Administration has approved a United Kingdom company's cannabis-based medicine for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.

According to a press release, the U.S. Food and Drug Administration (FDA) approved GW Pharma's drug Epidiolex for the treatment of rare forms of epilepsy. It is used to treat two rare forms of epilepsy in patients 2 years of age and older.

"Today's approval of epidiolex is a historic milestone, offering patients and their families the first and only FDA-approved CBD medicine to treat two severe, childhood-onset epilepsies", said Justin Gover, GW's Chief Executive Officer.

Epidiolex would also be the first approved therapy for DS, treatments for which are now limited to a combination of seizure medication and drugs to prevent emergencies.

Dravet syndrome appears in early childhood causing frequent seizures, impaired motor skills, and hyperactivity.

FDA commissioner, Scott Gottlieb, welcomed the news as an "important medical advance", and said that Epidiolex "provides new options for patients".

Epidiolex will be supplied as a 100mg/mL strawberry-flavored oral solution in 100mL bottles and is expected to be available for appropriate patients in Fall 2018. There are six other drugs approved to treat seizures associated with Lennox-Gastaut, but none approved for Dravet. Carriker said when combined with other medications, her daughter's seizures reduced by about 50 percent. As of last week, the company hadn't determined the price but was in preliminary talks with insurance companies to make them aware Epidiolex is coming, he said.

While the drug is made using the CBD, which is a component in Cannabis, it is nonpsychoactive, meaning it doesn't make you high.

A Strawberry Moon will sweeten up the night sky tonight
When it's in its full phase, the moon is incredibly bright and nearly impossible to look at for more than a few seconds. The Strawberry Moon rises over lower Manhattan and One World Trade Center on June 06, 2017 in Montclair, New Jersey.

Apple, Samsung resolve smartphone design fight after 7 years
When contacted by AFP for comment, Apple referred to a statement released last month after the jury announced the damages award. If you recall, Samsung was first sued by Apple in 2011 for copying the iPhone's design.

Voting officially ends in Turkey with AK Party leading
To achieve an outright victory and avoid a second round, Erdogan needs to secure more than 50 percent of the vote. Ince told a rally on Saturday he would lift the state of emergency within 48 hours of being elected president.

As a result, Epidiolex's launch remains at the discretion of the DEA, which must now evaluate the drug and consider reclassifying it as a substance that has medical properties, so as to allow GW to begin selling it.

The most common side effects that occurred in Epidiolex-treated patients in the clinical trials were: sleepiness, sedation and lethargy; elevated liver enzymes; decreased appetite; diarrhea; rash; fatigue, malaise and weakness; insomnia, sleep disorder and poor quality sleep; and infections.

"The DEA will need to make a different scheduling decision for CBD.because it now has an accepted medical use", he said during a conference call with reporters.

FDA's Gottlieb warned about the use of CBD products with "unproven medical claims".

Once that happens, marijuana startups will be able to sell their CBD-only products even in states where marijuana is illegal - as long as they register them with the DEA.

Now that FDA approval has been granted, the producers of the drug now expect for it to be available by the autumn.

The other epilepsy drugs in the market lead to serious risks like suicidal thoughts and attempts.